These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 20487417)

  • 1. Uncomplicated strongyloidiasis in a liver transplant recipient on steroid-free immunosuppression.
    Sen S; Dawwas MF; Nash KL; Gimson AE
    Transpl Infect Dis; 2010 Apr; 12(2):184-5. PubMed ID: 20487417
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin.
    Lichtenberger P; Rosa-Cunha I; Morris M; Nishida S; Akpinar E; Gaitan J; Tzakis A; Doblecki-Lewis S
    Transpl Infect Dis; 2009 Apr; 11(2):137-42. PubMed ID: 19144097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strongyloides stercoralis hyperinfection syndrome after liver transplantation: case report and literature review.
    Vilela EG; Clemente WT; Mira RR; Torres HO; Veloso LF; Fonseca LP; de Carvalho E Fonseca LR; Franca Md; Lima AS
    Transpl Infect Dis; 2009 Apr; 11(2):132-6. PubMed ID: 18983416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tacrolimus-induced cholestatic syndrome following pediatric liver transplantation and steroid-resistant graft rejection.
    Ganschow R; Albani J; Grabhorn E; Richter A; Burdelski M
    Pediatr Transplant; 2006 Mar; 10(2):220-4. PubMed ID: 16573611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of recurrent hepatitis C virus after liver transplantation in a randomized trial of tacrolimus monotherapy versus triple therapy.
    Manousou P; Samonakis D; Cholongitas E; Patch D; O'Beirne J; Dhillon AP; Rolles K; McCormick A; Hayes P; Burroughs AK
    Liver Transpl; 2009 Dec; 15(12):1783-91. PubMed ID: 19938143
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult liver transplantation and steroid-azathioprine withdrawal in cyclosporine (Sandimmun)-based immunosuppression - 5 year results of a prospective study.
    Lerut JP; Ciccarelli O; Mauel E; Gheerardhyn R; Talpe S; Sempoux C; Laterre PF; Roggen FM; Van Leeuw V; Otte JB; Gianello P
    Transpl Int; 2001 Dec; 14(6):420-8. PubMed ID: 11793040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rejection episodes after liver transplantation during primary immunosuppression with FK506 or a cyclosporine-based regimen: a controlled, prospective, randomized trial.
    Jonas S; Kling N; Bechstein WO; Blumhardt G; Lohmann R; Lobeck H; Neuhaus P
    Clin Transplant; 1995 Oct; 9(5):406-14. PubMed ID: 8541635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rejection rates in a randomised trial of tacrolimus monotherapy versus triple therapy in liver transplant recipients with hepatitis C virus cirrhosis.
    Samonakis DN; Mela M; Quaglia A; Triantos CK; Thalheimer U; Leandro G; Pesci A; Raimondo ML; Dhillon AP; Rolles K; Davidson BR; Patch DW; Burroughs AK
    Transpl Infect Dis; 2006 Mar; 8(1):3-12. PubMed ID: 16623815
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients.
    Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J
    Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strongyloides stercoralis hyperinfection in a renal allograft recipient.
    Meyers AM; Shapiro DJ; Milne FJ; Myburgh JA; Rabkin R
    S Afr Med J; 1976 Jul; 50(33):1301-2. PubMed ID: 785626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tacrolimus (FK 506)-induced hemolytic uremic syndrome after heart transplantation.
    Walder B; Ricou B; Suter PM
    J Heart Lung Transplant; 1998 Oct; 17(10):1004-6. PubMed ID: 9811409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early steroid withdrawal after liver transplantation: the Canadian tacrolimus versus microemulsion cyclosporin A trial: 1-year follow-up.
    Greig P; Lilly L; Scudamore C; Erb S; Yoshida E; Kneteman N; Bain V; Ghent C; Marotta P; Grant D; Wall W; Tchervenkov J; Barkun J; Roy A; Marleau D; McAlister V; Peltekian K
    Liver Transpl; 2003 Jun; 9(6):587-95. PubMed ID: 12783400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strongyloides hyperinfection syndrome after intestinal transplantation.
    Patel G; Arvelakis A; Sauter BV; Gondolesi GE; Caplivski D; Huprikar S
    Transpl Infect Dis; 2008 Apr; 10(2):137-41. PubMed ID: 17605735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tacrolimus based immunosuppression.
    First MR
    J Nephrol; 2004; 17 Suppl 8():S25-31. PubMed ID: 15599882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection.
    Lewis WD; Jenkins RL; Burke PA; Winn KM; Shaffer D; Lopez R; Monaco AP
    Transplant Proc; 1991 Dec; 23(6):2989-91. PubMed ID: 1721336
    [No Abstract]   [Full Text] [Related]  

  • 16. Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3?
    Dé P; Bechstein WO; Blumhardt G; Lange D; Schattenfroh N; Neuhaus P
    Transplant Proc; 1993 Aug; 25(4):2693-4. PubMed ID: 7689279
    [No Abstract]   [Full Text] [Related]  

  • 17. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-year follow-up of low dose tacrolimus oral therapy after liver transplantation: a single-centre experience.
    Rossi G; Reggiani P; Orsenigo R; Leoni L; Caccamo L; Doglia M; Gatti S; Maggi U; Paone G; Galmarini D; Fassati LR
    Transplant Proc; 1998 Jun; 30(4):1391-3. PubMed ID: 9636562
    [No Abstract]   [Full Text] [Related]  

  • 19. Primary immunosuppression with tacrolimus after liver transplantation: 12-years follow-up.
    Jonas S; Neuhaus R; Junge G; Klupp J; Theruvat T; Langrehr JM; Settmacher U; Neuhaus P
    Int Immunopharmacol; 2005 Jan; 5(1):125-8. PubMed ID: 15589470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strongyloides hyperinfection syndrome and transplantation: a preventable, frequently fatal infection.
    Marty FM
    Transpl Infect Dis; 2009 Apr; 11(2):97-9. PubMed ID: 19400809
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.